Guidance for commissioners on the cost effectiveness of smoking cessation interventions

Thorax

Volumn 53, Issue SUPPL. 5, 1998, Pages

  Parrott, Steve ^a   Godfrey, Christine ^a   Raw, Martin ^b   West, Robert ^c   McNeill, Ann ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH PRACTITIONER; HUMAN; LIFE EXPECTANCY; NICOTINE REPLACEMENT THERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SELF HELP; SMOKING CESSATION; SOCIAL SUPPORT; STATISTICAL ANALYSIS; SUBSTITUTION THERAPY;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; MALE; PREGNANCY; SMOKING CESSATION; STATE MEDICINE;

EID: 0032410535     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. Thorax 1998;53(Suppl 5, Part 1):S1-19.
2. Bück D, Godfrey C. Helping smokers give up: guidance for purchasers on cost effectiveness. London: Health Education Authority, 1994.
3. Tengs TO, Adams ME, Pilskin JS, et al. Five hundred life saving interventions and their cost effectiveness. Risk Analysis 1995;15:369-90.
4. Raw M, Godfrey C, Burrows S. An estimate of government expenditure on smoking cessation in the UK. In Coughing up: what smokers want to help them quit and who they think should pay. London: No Smoking Day, 1998.
5. Callum C. The UK smoking epidemic: deaths in 1995. London: Health Education Authority, 1998.
6. Godfrey C, Raw M, Sutton M, et al. The smoking epidemic: a prescription for change. London: Health Education Authority, 1993.
7. Buck D, Godfrey C, Parrott S, et al. Cost effectiveness of smoking cessation interventions. London: Health Education Authority, 1997.
8. NHS Executive. Burdens of disease: a discussion document. Leeds: NHS Executive, 1996.
9. Institute of Public Health. The health of the nation: public health common data set, 1994. England, Volume 3. Institute of Public Health, University of Surrey.
10. Bennett N, Jarvis L, Rowlands O, et al. Living in Britain: results from the 1994 General Household Survey. London: HMSO.
11. Treasury. The Government's Expenditure Plans 7995-6 to 1997-8. London: HMSO, 1995.
12. CIPFA. Health service financial database, 1996. Croydon: Institute of Public Finance, 1997.
13. NHS Management Executive. Health service indicators 1994/5. Leeds: NHS Management Executive, 1996.
14. Maynard A. Developing the health care market. Economic J 1991;101:1277-86.
15. Mason J, Drummond M, Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ 1993;306: 570-2.
16. Drummond M, Mason J, Torrance G. Cost effectiveness league tables: think of the fans. Health Policy 199531:231-8.
17. Tillmann M, Silcock J. A comparison of smokers' and ex-smokers' health related quality of life. J Public Health Med 1997;19:268-73.
18. Drummond MF, O'Brien BJ, Stoddart GL, et al. Methods for the economic evaluation of health care programmes 2nd edn. Oxford: Oxford University Press, 1997.
19. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Mittbank Quarterly 1992;70:81-125.
20. Barendregt JJ, Bonneux L, Van De Maas PJ. The health care costs of smoking. N EnglJMed 1997;337:1052-7.
21. Gold MR, Siegel JE, Russell LB, et al. Cost effectiveness in health and medicine. New York: Oxford University Press, 1996.
22. Silagy C, Mant D, Fowler G, et al. Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane Library Issue 2. Oxford: Update Software, 1998. Updated quarterly.
23. McColl A, Smith H, White P, et al. General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey. BMJ1998;316:361-5.
24. NHS Centre for Reviews and Dissemination. Effectiveness Matters 3.1: Smoking cessation: what the health service can do. York: University of York, 1998.
25. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Guideline Technical Report 18. Rockville: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. Publication No. AHCPR 97-N004, October 1996.
26. Gunning-Schepers L. The health benefits of prevention: a simulation approach. Health Policy 1989;12:l-255.
27. Jarvis M. Patterns and predictors of smoking cessation in the general population. In: Bolliger C, Fagerstrom KO, eds. The tobacco epidemic. Basel: Karger, 1997: 151-64.
28. Hughes D. Costing consultations in general practice: towards a standardised approach. Family Practice 1991 ;8: 388-93.
29. West R. Getting serious about stopping smoking: a review of products and services. London: No Smoking Day, 1997.
30. Shiftman S, Gitchell J, Pinney J, et al. Public health benefit of over the counter nicotine medications. Tobacco Control 1998;6:306-10.
31. Hughes JR. Pharmacotherapy of nicotine dependence. In: Schuster CR, Kuhar MJ, eds. Pharmacological aspects of drug dependence: towards an integrative neurobehavioral approach. New York: Springer-Verlag, 1996: 599-626.
32. Fowler G. Smoking cessation: the role of general practitioners, nurses and pharmacists. In: Bolliger CT, Fagerstrom KO, eds. The tobacco epidemic. Basel: Karger, 1997: 165-77.
33. Curry SJ, Grothaus LC, McAfee T, et al. Use and cost effectiveness of smoking cessation services under four insurance plans in a health maintenance organisation. AT Engl J Med 1998;339:673-9.
34. Department of Health. Policy appraisal and health: a guide from the Department of Health. London: HMSO, 1995.
35. Shipley RH, Hartwell TD, Austin WD, et al. Community stop-smoking contests in the COMMIT trial: relationship of participation to costs. Preventive Med 1995;24:286-92.
36. Phillips CJ, Prowle MJ. Economics of a reduction in smoking: case study from Heartbeat Wales. J Epidemiol Community Health 1993;47:215-23.
37. Foster K, Jackson B, Thomas M, et al. General Household Survey 1993. London: HMSO, 1995.
38. Department of Health and Social Security/General Medical Services Committee. General medical practitioners'workload survey 1989-90. A report prepared for the Doctors' and Dentists' Review Body (DDRB), 1990.
39. Gough CB. Review body on doctors'and dentists'remuneration. 26th Report. London: The Stationery Office, 1997.
40. Department of Health. General medical services statistics: England and Wales. Department of Health, 1996.
41. Automobile Association. Travel Costs, 1997.
42. Office for National Statistics. Labour Market Trends, November 1997.
43. Monthly Index of Medical Specialties. Loughborough: Haymarket Publishing Services, October 1997.
44. Stapleton JA, Russell MA, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995;90: 31-40.
45. Willis NJM. The Smoking Cessation Service: Canterbury and Thanet Health Promotion Unit. Service Report April 1995September 1997 (unpublished).
46. Reid R, Smith N. What is the single most important intervention for the prevention of smoking related disease? Based on paper presented at Seventh World Conference on Tobacco and Health, Perth, Western Australia, 1-5 April 1990 (unpublished).
47. Thomas M, Walker A, Wilmot A, & Bennett, M. Living in Britain: results from the 1996 General Household Survey. London: The Stationery Office, 1998.
48. Baxter T, Milner P, Wilson K, et al. A cost effective, community based heart health promotion project in England: prospective comparative study. BMJ 1997315: 582-5.
49. Mudde AN, de Vries H, Stretcher VJ. Cost effectiveness of smoking cessation modalities: comparing apples with oranges? Preventive Med 1996;25:708-16.
50. Akehurst R, Piercy J. Cost effectiveness of the use of transdermal Nicorette patches relative to GP counselling and nicotine gum in the prevention of smoking related diseases. Brjf Med Econ 1994;7:115-22.
51. Krumhol? HM, Cohen BJ, Tsevat J, et al. Cost effectiveness of a smoking cessation program after myocardial infarction. JAm Coll Cardiol 1993;22:1697-702.
52. Wasley MA, McNagny SE, Phillips VL, el al. The cost effectiveness of the nicotine transdermal patch for smoking cessation. Preventive Med 1997;26:264-70.
53. Leinweber CE, Macdonald JM, Campbell HS. Community stop smoking contests: an effective public health strategy. Can J Public Health 1994;85:95-8.
54. Fiscella K, Franks P. Cost effectiveness of the transdermal nicotine patch as an adjunct to physicians smoking cessation counselling. JAMA 1996;275:1247-51.
55. Law M, Ling Tang J. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995;155:1933-41.
56. Stevermer J. Is the addition of a transdermal nicotine patch to brief office counseling cost-effective? J Family Pract 1996; 43:125-6.
57. Cheung AM, Tsevat J. Economic evaluations of smoking interventions. Preventive Med 1997;26:271-3.
58. Oster G, Huse DM, Delea TE, et al. Cost effectiveness of nicotine gum as an adjunct to physicians' advice against cigarette smoking. JAMA 1986;256:1315-18.
59. Warner KE. (1997) Cost effectiveness of smoking cessation therapies: interpretation of the evidence and implications for coverage. Pharmacoeconomics 1997;ll:538-49.
60. Cromwell J, Bartosch WJ, Fiore M, et al. Cost effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997;278:1759-66.
61. Cox JL, McKenna JP. Nicotine gum: does providing it free in a smoking cessation program alter success rates? J Family Pract 1990;31:278-80.
62. Williams A. Screening for risk of CHD: is it a wise use of resources? In: Oliver M, Ashley-Miller M, Wood D, eds. Screening for risk of coronary heart disease. John Wiley, 1987: 97-105.
63. Cummings SR, Rubin SM, Oster G. The cost effectiveness of counseling smokers to quit. JAMA 1989;261:75-9.
64. McParlane EC, Dolan-Mullen P, DeNino LA. The cost effectiveness of an education outreach representative to OB practitioners to promote smoking cessation. Patient Educ Smoking 1987;9:263-4.
65. Cepeda-Benito C. Meta-analytical review of the efficacy of nicotine chewing gum in smoking tretament programmes. J Consult Clin Psychol 1993;61:822-30.
66. Silagy C, Mont D, Fowler G, et al. Meta analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994343:139-42.
67. Tonnesen P, Norregaard J, Sawe U. Two year outcome in a smoking cessation trial with a nicotine patch. J Smoking Related Dis 1992;3:241-5.
68. Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16 hour transdermal nicotine patch in a medical practice setting without intensive group counselling. Arch Intern Med 1993; 153:1881-90.
69. Aberg A, Bergstrand R, Johansson S, et al. Cessation of smoking after myocardial infarction: effects on mortality after 10 years. Br Heart J 1983;49:416-22.
70. Korhonen HJ, Niemensiva H, Piha T. National TV smoking cessation program and contest in Finland. Preventive Med 1992;21:74-87.
71. Warner KE, Smith RJ, Smith DG, et al. Health and economic implications of a worksite smoking-cessation program: a simulation analysis. J Occup Environ Med 1996; 38:981-92.
72. Ratcliffe J, Cairns J, Platt S. Cost effectiveness of a mass media-led anti-smoking campaign in Scotland. Tobacco Conm>/1997;6:104-10.
73. Townsend J. Cost effectiveness and mass media programmes of smoking control. In: Crofton J, Wood M, eds. Smoking control: strategies and evaluation in community and mass media programmes. Ulster Cancer Foundation/Health Education Council, 1986.
74. Farquhar JW, Fortmann SP, Flora JP, et al Effects of communitywide education on cardiovascular disease risk factors. JAMA 1990;264:359-65.
75. NOP Market Research Ltd. Kathy 1. Health Education Council, 1985.
76. NOP Market Research Ltd. Kathy 2. Evaluation of the Campaign. Health Education Council, 1985.
77. NOP Market Research Ltd. Overall review of the Kathy campaign. Health Education Council, 1985.
78. Flay BR. Selling the smokeless society. Washington, DC: American Public Health Association, 1987.
79. Altman DG, Flora JA, Fortmann SP, el al. The cost effectiveness of three smoking cessation programs. Am J' Public Health 1987;77:162-5.
80. Best JA. Mass media, self management and smoking modification. In: Davidson PO, Davidson SM, eds. Behavioural' medicine: changing health lifestyles. New York: Bruner/Mazel, 1980.
81. Danaher BG, Berkanovic E, Gerber B.Mass media based health behaviour change: televised smoking cessation program. Addictive Behav 1984:245-53.
82. Flynn BS, Worden JK, Seeker-Walker RH, el al. Prevention of cigarette smoking though mass media intervention and school programs. Am J Public Health 1992;82:827-34.
83. Ershoff DH, Quinn VP, Dolan Müllen P, et al. Pregnancy and medical cost outcomes of a self help prenatal smoking cessation program in a HMD. Public Health Rep 1990;105: 340-7.
84. Marks JS, Koplan JP, Hogue CJR, et al. A cost-benefit/cost effectiveness analysis of smoking cessation for pregnant women. Am J Prevent Med 1990;6:282-9.
85. Windsor RA, Lowe JB, Perkins LL, et al. Health education for pregnant smokers: its behavioral impact and cost benefit. Am J Public Health 1993;83:201-6.